ONCOLOGY DRUG DISCOVERY AND CLINICAL-TRIAL TESTING - WHOS LISTENING - REPLY

被引：0

作者：

SEITZ, DE

机构：

[1] Lilly Research Laboratories, Indianapolis, IN

来源：

CANCER INVESTIGATION | 1994年 / 12卷 / 01期

关键词：

D O I：

10.3109/07357909409021401

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：107 / 108

页数：2

共 6 条

[1] INDUCTION OF REMISSION IN HEPATOCELLULAR-CARCINOMA WITH A NEW THYMIDYLATE SYNTHASE INHIBITOR, CB3717 - A PHASE-II STUDY [J].

BASSENDINE, MF ;

CURTIN, NJ ;

LOOSE, H ;

HARRIS, AL ;

JAMES, OFW .

JOURNAL OF HEPATOLOGY, 1987, 4 (03) :349-356

[2] THE EFFICACY OF 5-FLUOROURACIL IN HUMAN COLORECTAL-CANCER IS NOT ENHANCED BY THYMIDYLATE SYNTHETASE INHIBITION WITH CB3717 (N-10-PROPARGYL-5,8 DIDEAZAFOLIC ACID) [J].

CANTWELL, BMJ ;

HARRIS, AL .

BRITISH JOURNAL OF CANCER, 1988, 58 (02) :189-190

[3]

CANTWELL BMJ, 1986, CANCER TREAT REP, V70, P1335

[4] PHASE-II STUDY OF THE ANTIFOLATE N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB-3717) IN ADVANCED BREAST-CANCER [J].

CANTWELL, BMJ ;

MACAULAY, V ;

HARRIS, AL ;

KAYE, SB ;

SMITH, IE ;

MILSTED, RAV ;

CALVERT, AH .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04) :733-736

[5]

GALIVAN J, 1987, CANCER RES, V47, P5256

[6] PHASE-II STUDY OF THE THYMIDYLATE SYNTHETASE INHIBITOR CB3717 (N10-PROPARGYL-5, 8-DIDEAZAFOLIC ACID) IN COLORECTAL-CANCER [J].

HARDING, MJ ;

CANTWELL, BMJ ;

MILSTEAD, RAV ;

HARRIS, AL ;

KAYE, SB .

BRITISH JOURNAL OF CANCER, 1988, 57 (06) :628-629

← 1 →